Amgen to repurchase $5bn of stock through debt raise
This article was originally published in Scrip
Executive Summary
Amgen impressed investors with its plan to repurchase $5 billion worth of shares. The world's largest biotech firm rose almost 6% to $58.43 at close on 7 November following the announcement.